COMP <GO>
PODD vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Insulet Corporation (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: PODD 7
— JNJ 6
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: PODD
LAST: $149.68 (-1.85%) • MKT CAP: $10.58B
options-implied-move
6.90%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
options-implied-move
7.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PODD VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PODD | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.60% | 67.90% | +3.70 | PODD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.40% | 25.50% | -5.10 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.1x | 18.5x | -1.40 | PODD | /valuation <GO> |
| Free Cash Flow Yield | 3.57% | 2.97% | +0.60 | PODD | /fcf-yield <GO> |
| Operating Margin | 17.50% | 34.70% | -17.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 9.10% | 28.50% | -19.40 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 30.70% | 6.00% | +24.70 | PODD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.72 | 5.59 | +0.13 | PODD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.90% | 7.20% | -0.30 | PODD | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.4 | 60.4 | +2.00 | PODD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.08 | -0.09 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 23.0x | +13.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.58B | $662.49B | -$651.92B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PODD REV | JNJ REV | PODD GROSS % | JNJ GROSS % | PODD FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.71B | $94.19B | 71.6% | 67.9% | $377.7M | $19.70B |
| FY 2024 | $2.07B | $88.82B | 69.8% | 69.1% | $305.3M | $19.84B |
| FY 2023 | $1.70B | $85.16B | 44.0% | 44.0% | $69.3M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PODD // BETA 0.99
JNJ // BETA 1.08